BRINGING
DISCOVERIES
TO LIFE
We connect academic research with industry to drive
therapeutic discoveries
RESEARCH
PARTNERSHIPS
ENTERPRISE
RESEARCH
Our goal is the discovery of new targets for the treatment of disease. Our research teams focus on the development of human models of disease and the use of gene editing to better understand how diseases arise, and the application of artificial intelligence and quantum computing to interrogate large patient and human tissue-based datasets.
PARTNERSHIPS
We have built a community of >90 academic, industry and investor organisations to drive therapeutic discovery through cross-sector partnerships. This includes the Milner Therapeutics Consortium (consisting of 10 pharma partners and 3 academic institutions) and an extended network of affiliates. Together our community collectively drives therapeutics strategies through collaboration.
ENTERPRISE
Our comprehensive support system is designed to facilitate the growth of entrepreneurial ventures from conception to realization. We offer programmes in educational ideation, entrepreneurship and skills development, incubation facilities for young companies, a founders community, and pitch events with investors.
